| Product Code: ETC320729 | Publication Date: Aug 2022 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Philippines continues to rely heavily on imports of corticosteroids, with key suppliers in 2024 being China, Brazil, Thailand, Malaysia, and Taiwan. The market remains highly concentrated, as indicated by the high Herfindahl-Hirschman Index (HHI). The impressive compound annual growth rate (CAGR) of 30.92% from 2020 to 2024 underscores the increasing demand for corticosteroids in the country. Moreover, the remarkable growth rate of 64.33% from 2023 to 2024 demonstrates a significant uptick in import shipments, reflecting a robust market for corticosteroids in the Philippines.

Experiencing a CAGR of approximately 4.6%, the corticosteroid market in the Philippines is driven by their application in various medical treatments.
The corticosteroid market in the Philippines is primarily driven by the rising prevalence of inflammatory and autoimmune diseases. The increasing awareness among healthcare professionals about the effectiveness of corticosteroids in managing these conditions is leading to their widespread prescription. Moreover, the growing elderly population and the associated rise in age-related ailments are boosting the demand for corticosteroid-based treatments in the country.
The Philippines Corticosteroid market grapples with a range of challenges related to healthcare and pharmaceuticals. One notable challenge is striking a balance between the therapeutic benefits of corticosteroids and their potential side effects. Ensuring proper patient education and healthcare provider guidance is crucial to avoid misuse and adverse reactions. Regulatory compliance and market approval processes also pose challenges, as stringent requirements must be met to ensure the safety and efficacy of corticosteroid products. Moreover, the market must address accessibility and affordability issues to ensure that patients can benefit from these treatments without financial strain.
The Philippines corticosteroid market has witnessed fluctuations in demand during the pandemic. Corticosteroids are used in the treatment of various inflammatory and immune-related conditions. The market has seen increased demand for corticosteroids for the treatment of COVID-19 patients.
Some key players in the Philippines market for corticosteroids include GlaxoSmithKline, Pfizer Inc., and Merck & Co., Inc.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Corticosteroid Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Corticosteroid Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Corticosteroid Market - Industry Life Cycle |
3.4 Philippines Corticosteroid Market - Porter's Five Forces |
3.5 Philippines Corticosteroid Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Philippines Corticosteroid Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.7 Philippines Corticosteroid Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Philippines Corticosteroid Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of skin disorders and autoimmune diseases in the Philippines |
4.2.2 Growth in healthcare infrastructure and access to healthcare services |
4.2.3 Rising awareness about corticosteroid treatment among healthcare professionals and patients |
4.3 Market Restraints |
4.3.1 Stringent government regulations and policies regarding corticosteroid usage |
4.3.2 High competition from alternative treatment options such as herbal remedies and alternative medicines |
5 Philippines Corticosteroid Market Trends |
6 Philippines Corticosteroid Market, By Types |
6.1 Philippines Corticosteroid Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Philippines Corticosteroid Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Philippines Corticosteroid Market Revenues & Volume, By Glucocorticoids, 2021-2031F |
6.1.4 Philippines Corticosteroid Market Revenues & Volume, By Mineralocorticoids, 2021-2031F |
6.2 Philippines Corticosteroid Market, By Administration |
6.2.1 Overview and Analysis |
6.2.2 Philippines Corticosteroid Market Revenues & Volume, By Topical Steroids, 2021-2031F |
6.2.3 Philippines Corticosteroid Market Revenues & Volume, By Inhaled Steroids, 2021-2031F |
6.2.4 Philippines Corticosteroid Market Revenues & Volume, By Oral Forms, 2021-2031F |
6.2.5 Philippines Corticosteroid Market Revenues & Volume, By Systemic Forms, 2021-2031F |
6.2.6 Philippines Corticosteroid Market Revenues & Volume, By Others, 2021-2031F |
6.3 Philippines Corticosteroid Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Philippines Corticosteroid Market Revenues & Volume, By Rheumatology Indications, 2021-2031F |
6.3.3 Philippines Corticosteroid Market Revenues & Volume, By Skin Allergies, 2021-2031F |
6.3.4 Philippines Corticosteroid Market Revenues & Volume, By Endocrinology, 2021-2031F |
6.3.5 Philippines Corticosteroid Market Revenues & Volume, By Gastroenterology, 2021-2031F |
6.3.6 Philippines Corticosteroid Market Revenues & Volume, By Acute Respiratory Diseases, 2021-2031F |
6.3.7 Philippines Corticosteroid Market Revenues & Volume, By Others, 2021-2031F |
7 Philippines Corticosteroid Market Import-Export Trade Statistics |
7.1 Philippines Corticosteroid Market Export to Major Countries |
7.2 Philippines Corticosteroid Market Imports from Major Countries |
8 Philippines Corticosteroid Market Key Performance Indicators |
8.1 Number of dermatology clinics and hospitals offering corticosteroid treatments |
8.2 Percentage of healthcare professionals trained in corticosteroid usage |
8.3 Patient adherence rate to corticosteroid treatment plans |
8.4 Average time taken for patients to receive corticosteroid treatment after diagnosis |
9 Philippines Corticosteroid Market - Opportunity Assessment |
9.1 Philippines Corticosteroid Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Philippines Corticosteroid Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.3 Philippines Corticosteroid Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Philippines Corticosteroid Market - Competitive Landscape |
10.1 Philippines Corticosteroid Market Revenue Share, By Companies, 2024 |
10.2 Philippines Corticosteroid Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here